HARMONY BIOSCIENCES TO PARTICIPATE IN 21st ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Harmony Biosciences Holdings, based in Plymouth Meeting, PA, will present a company update at the 21st Annual Needham Virtual Healthcare Conference on April 11, 2022. CEO John C. Jacobs will lead a fireside chat from 12:45 p.m. to 1:25 p.m. ET and participate in 1x1 meetings on the same day. Investors can access a webcast of the chat on Harmony's investor page. Harmony focuses on innovative therapies for rare neurological diseases, aiming to address unmet medical needs.
Details
News Market Reaction – HRMY
The recorded move for HRMY in the trading session of this news was -0.24%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PLYMOUTH MEETING, Pa., April 4, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs, will present a company update and host investor meetings at the upcoming 21st Annual Needham Virtual Healthcare Conference.
- 21st Annual Needham Virtual Healthcare Conference
Fireside Chat: Monday, April 11; 12:45 p.m.-1:25 p.m. ET
1x1 Meetings: Monday, April 11
A webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological disorders who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.
Harmony Biosciences Investor Contact:
Patti Bank
ICR Westwicke
415-513-1284
ir@harmonybiosciences.com
Harmony Biosciences Media Contact:
Nancy Leone
215-891-6046
nleone@harmonybiosciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-21st-annual-needham-virtual-healthcare-conference-301515924.html
SOURCE Harmony Biosciences
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.